{"id":6835,"date":"2026-07-12T00:40:02","date_gmt":"2026-07-11T23:40:02","guid":{"rendered":"https:\/\/lenus-healthcare.com\/?p=6835"},"modified":"2026-07-07T09:00:42","modified_gmt":"2026-07-07T08:00:42","slug":"branded-medicines-wholesale-europe","status":"publish","type":"post","link":"https:\/\/lenus-healthcare.com\/en\/branded-medicines-wholesale-europe\/","title":{"rendered":"Branded Medicines Wholesale from Europe: What International Buyers Need to Know"},"content":{"rendered":"<p>Branded medicines wholesale from Europe is one of the most specialised areas of international pharmaceutical supply. Unlike generic medicines \u2014 where procurement decisions are driven primarily by price and documentation \u2014 branded pharmaceuticals involve a more complex set of considerations: national marketing authorisations, destination-country registration requirements, parallel trade regulations, and distribution restrictions that major pharmaceutical manufacturers impose on their products.<\/p>\n<p>According to the IQVIA Institute&#8217;s Global Medicine Use Trends 2026 report, branded medicines still account for more than 70 percent of the total value of the global pharmaceutical market, even as generics dominate by volume. This gap reflects the continued importance of branded pharmaceuticals in high-value therapeutic categories \u2014 oncology, immunology, rare diseases, and biologics \u2014 where demand is growing rapidly in the Middle East, Central Asia, and Latin America.<\/p>\n<p>For healthcare organisations in these markets, access to branded medicines with European origin and complete EMA documentation is not a competitive advantage. It is an operational requirement. Regulatory authorities in many of these regions specifically recognise documentation issued by European regulatory bodies as part of their import approval processes.<\/p>\n<p>In this article, we explain what branded medicines are, why sourcing them from Europe carries distinct advantages for international buyers, what challenges arise in this supply chain, and what criteria matter most when selecting a reliable European branded medicine distributor.<\/p>\n<blockquote><p><a href=\"https:\/\/lenus-healthcare.com\/en\/contact-us\/#form-contact\"><strong>For international supply and commercial inquiries regarding this product, please contact the Lenus Health sales team.<\/strong><\/a><\/p><\/blockquote>\n<p><strong>Table of Contents<\/strong><\/p>\n<ol>\n<li><a href=\"#What\">What Are Branded Medicines?<\/a><\/li>\n<li><a href=\"#Why\">Why Branded Medicines Still Hold a Major Market Share<\/a><\/li>\n<li><a href=\"#Branded\">Branded vs Generic Medicines: Comparison Table<\/a><\/li>\n<li><a href=\"#Challenges\">The Challenges of Sourcing Branded Medicines from Europe<\/a><\/li>\n<li><a href=\"#Documentation\">Documentation Requirements for Branded Medicine Imports<\/a><\/li>\n<li><a href=\"#Primary\">Primary Uses of Branded Medicines in International Markets<\/a><\/li>\n<li><a href=\"#Select\">How to Select a Reliable European Branded Medicine Distributor<\/a><\/li>\n<li><a href=\"#Conclusion\">Conclusion<\/a><\/li>\n<li><a href=\"#faq\">Frequently Asked Questions<\/a><\/li>\n<\/ol>\n<h2 id=\"What\">1. What Are Branded Medicines?<\/h2>\n<p>A branded medicine is a pharmaceutical product manufactured and marketed by the company that originally developed it, sold under a proprietary trade name. These medicines are the result of years of research, clinical trials, and regulatory approval, and during the patent exclusivity period, only the originating manufacturer may legally produce and sell the product. In pharmaceutical terminology, branded medicines are also referred to as innovator medicines, originator products, or reference medicines.<\/p>\n<p>One point that is frequently misunderstood is that branded does not mean clinically superior to generic. Once a patent expires, generic versions that have demonstrated bioequivalence are considered therapeutically equivalent by the EMA. But during the exclusivity period \u2014 and for medicines where no qualified generic yet exists \u2014 the branded product is the only available treatment option.<\/p>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europe01.jpg\" alt=\"What Are Branded Medicines?\" width=\"100%\" height=\"auto\" \/><\/p>\n<p>The branded medicine categories with the highest demand in international markets include:<\/p>\n<ul>\n<li>Oncology: imatinib (Gleevec), trastuzumab (Herceptin), pembrolizumab (Keytruda), and targeted therapies<\/li>\n<li>Immunology and rheumatology: adalimumab (Humira), etanercept (Enbrel), and newer IL inhibitors<\/li>\n<li>Diabetes and obesity: next-generation GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy)<\/li>\n<li>Rare diseases: enzyme replacement therapies and ultra-orphan drug designations<\/li>\n<li>Antivirals: branded HIV treatment regimens and hepatitis C direct-acting antiviral combinations<\/li>\n<\/ul>\n<p>What makes these categories important in international markets is that for most of them, no qualified generic alternative currently exists. For patients who require these treatments, access to reliable branded medicine supply from a trusted European source has a direct impact on treatment outcomes.<\/p>\n<h2 id=\"Why\">2. Why Branded Medicines Still Hold a Major Market Share<\/h2>\n<p>A question that procurement teams frequently raise is straightforward: if generic medicines are cheaper and more widely available, why does demand for branded pharmaceuticals remain so high? The answer lies in several structural factors that are not going to change in the near term.<\/p>\n<p>The key drivers of sustained branded medicine demand include:<\/p>\n<ul>\n<li>Patent exclusivity: many high-value branded medicines remain under patent protection with no qualified generic alternative available<\/li>\n<li>Biologic complexity: in the biologics category, switching from a branded reference medicine to a biosimilar involves clinical and regulatory considerations that many treatment protocols do not permit without physician approval<\/li>\n<li>Market trust: in several international markets, physicians and patients have a stronger confidence in branded medicines, even when an equivalent generic is available<\/li>\n<li>Clinical protocol specifications: some international treatment guidelines specify branded products by name, making substitution conditional on physician approval<\/li>\n<\/ul>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europe00.jpg\" alt=\"Branded vs Generic Medicines\" width=\"100%\" height=\"auto\" \/><\/p>\n<p>The practical implication is that the branded medicine market is growing alongside generics, not being replaced by them. For organisations operating in oncology, rare disease, or speciality therapeutic areas, consistent access to European-origin branded medicines is a strategic operational requirement.<\/p>\n<h2 id=\"Branded\">3. Branded vs Generic Medicines: Comparison Table<\/h2>\n<p>For procurement teams evaluating whether to source a branded or generic version of a specific medicine, a clear side-by-side comparison helps frame the decision:<\/p>\n<table class=\"tbl-border\">\n<tbody>\n<tr>\n<td><strong>Criteria<\/strong><\/td>\n<td><strong>Branded Medicine<\/strong><\/td>\n<td><strong>Generic Medicine<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>Manufacturer<\/strong><\/td>\n<td>Original developer only<\/td>\n<td>Other qualified manufacturers<\/td>\n<\/tr>\n<tr>\n<td><strong>Patent status<\/strong><\/td>\n<td>Usually under exclusivity<\/td>\n<td>Patent expired<\/td>\n<\/tr>\n<tr>\n<td><strong>Regulatory standard<\/strong><\/td>\n<td>EMA or national authority<\/td>\n<td>EMA or national authority (same)<\/td>\n<\/tr>\n<tr>\n<td><strong>GMP requirement<\/strong><\/td>\n<td>Mandatory<\/td>\n<td>Mandatory (same)<\/td>\n<\/tr>\n<tr>\n<td><strong>Therapeutic efficacy<\/strong><\/td>\n<td>Clinically proven<\/td>\n<td>Proven via bioequivalence<\/td>\n<\/tr>\n<tr>\n<td><strong>Price<\/strong><\/td>\n<td>Higher<\/td>\n<td>20 to 80% lower<\/td>\n<\/tr>\n<tr>\n<td><strong>Market availability<\/strong><\/td>\n<td>More restricted<\/td>\n<td>Broader<\/td>\n<\/tr>\n<tr>\n<td><strong>Registration complexity<\/strong><\/td>\n<td>Higher in many markets<\/td>\n<td>Simpler in familiar markets<\/td>\n<\/tr>\n<tr>\n<td><strong>Substitutability<\/strong><\/td>\n<td>Limited during patent<\/td>\n<td>Usually high<\/td>\n<\/tr>\n<tr>\n<td><strong>Export documentation<\/strong><\/td>\n<td>Full EMA documentation<\/td>\n<td>Full EMA documentation (same)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>What this comparison makes clear is that from a regulatory and quality standpoint, both categories operate under the same European standards. The meaningful differences are in patent status, price, and the complexity of the sourcing process.<\/p>\n<h2 id=\"Challenges\">4. The Challenges of Sourcing Branded Medicines from Europe<\/h2>\n<p>Sourcing branded medicines from Europe involves a different set of operational challenges compared to generic pharmaceutical procurement. Understanding these challenges before engaging a supplier helps procurement teams set realistic expectations and avoid delays that can have direct clinical consequences.<\/p>\n<p>The main challenges procurement teams typically encounter include:<\/p>\n<ul>\n<li><strong>Distribution restrictions<\/strong>: Many large pharmaceutical manufacturers operate controlled regional distribution networks. This means a European wholesaler cannot simply export any branded medicine to any destination. Some products are only available through the manufacturer&#8217;s authorised distribution channels.<\/li>\n<li><strong>Parallel trade<\/strong>: Within the European Union, parallel trade in medicines between member states is legal. Price differences between countries create sourcing opportunities for knowledgeable distributors, but parallel-traded products require specific repackaging and relabelling procedures.<\/li>\n<li><strong>Destination-country registration<\/strong>: A branded medicine with valid EMA authorisation in Europe is not automatically registered in the destination country. Importers must confirm that the specific product is registered in their country, or determine whether it can be imported via a special access pathway.<\/li>\n<li><strong>Limited stock availability<\/strong>: Unlike high-volume generic pharmaceuticals, branded medicines are not always held in large quantities in wholesale distribution centres. Stock can be limited and lead times can be longer.<\/li>\n<\/ul>\n<p>Despite these challenges, working with a distribution partner that has the right relationships, regulatory knowledge, and operational experience makes most of these obstacles manageable.<\/p>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europe04.jpg\" alt=\"Branded Medicine Imports\" width=\"100%\" height=\"auto\" \/><\/p>\n<h2 id=\"Documentation\">5. Documentation Requirements for Branded Medicine Imports<\/h2>\n<p>Documentation is the foundation of any successful branded medicine import. An incomplete documentation package can result in shipments being held at customs, import refusals, or multi-week delays with direct clinical impact. Knowing the requirements before placing an order is essential.<\/p>\n<p>The documents typically required for international branded medicine imports include:<\/p>\n<ul>\n<li>Certificate of Pharmaceutical Product (CPP): issued by BfArM in Germany or the competent authority of the origin country<\/li>\n<li>Certificate of Analysis (CoA): batch-specific analytical test results confirming compliance with the product specification<\/li>\n<li>GMP Certificate: issued by an EU national competent authority, confirming the branded manufacturer&#8217;s GMP compliance<\/li>\n<li>Batch Release Records: confirming release of the specific batch by a Qualified Person in the EU<\/li>\n<li>Free Sale Certificate: confirming the product holds a valid marketing authorisation in the country of export<\/li>\n<li>Import permit or registration confirmation: depending on destination-country requirements<\/li>\n<\/ul>\n<p>Beyond this standard documentation package, specific markets have additional requirements. In Saudi Arabia, SFDA requires prior product registration. In Kazakhstan and Uzbekistan, EU certificates form a strong basis but often require notarisation. In Brazil and Colombia, independent national registration systems apply.<\/p>\n<h2 id=\"Primary\">6. Primary Uses of Branded Medicines in International Markets<\/h2>\n<p>In most international markets, demand for branded medicines is concentrated in specific therapeutic categories. Understanding where branded medicine demand is highest helps procurement teams align their sourcing strategies with the areas where supply reliability matters most.<\/p>\n<p>The therapeutic categories with the greatest branded medicine demand in international markets include:<\/p>\n<ul>\n<li><strong>Oncology<\/strong>: The largest source of branded medicine demand in emerging markets. Most next-generation cancer treatments remain under patent with no qualified generic alternative available.<\/li>\n<li><strong>Type 2 diabetes and obesity<\/strong>: Next-generation GLP-1 receptor agonists remain under patent protection and are experiencing rapidly growing demand in Gulf markets. Generic alternatives are not yet available.<\/li>\n<li><strong>Inflammatory diseases<\/strong>: Biologic medicines for rheumatoid arthritis, Crohn&#8217;s disease, and psoriasis remain branded in many markets and are subject to strict physician-led prescribing requirements.<\/li>\n<li><strong>HIV and hepatitis C<\/strong>: Some treatment protocols specifically require branded antiretroviral or direct-acting antiviral combinations.<\/li>\n<li><strong>Rare diseases<\/strong>: This category has no generic alternatives by definition. Medicines must be sourced as branded products, typically with complex documentation requirements.<\/li>\n<\/ul>\n<p>An important point across all of these categories is that accurate documentation is not just a regulatory requirement but a clinical necessity. Hospital pharmacy committees require assurance of product origin and integrity, and EMA-sourced documentation provides that assurance in a form that is widely recognised.<\/p>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2026\/06\/generic-medicines-supplier01.jpg\" alt=\"HIV and hepatitis C\" width=\"100%\" height=\"auto\" \/><\/p>\n<h2 id=\"Select\">7. How to Select a Reliable European Branded Medicine Distributor<\/h2>\n<p>Choosing the right European distribution partner for branded medicines is a decision that should be made carefully and on the basis of verifiable criteria. An unsuitable partner can create documentation gaps, introduce delays, or in the worst case, result in a shipment being stopped at the destination border.<\/p>\n<p>The criteria that matter most when evaluating a branded medicine distributor include:<\/p>\n<ul>\n<li><strong>WDL authorization<\/strong>: The distributor must hold a valid Wholesale Dealer License issued by a competent authority in Germany or the relevant EU country of origin.<\/li>\n<li><strong>GDP compliance<\/strong>: Storage, handling, and distribution operations must comply with EU Good Distribution Practice guidelines.<\/li>\n<li><strong>Documentation transparency<\/strong>: Before any order is placed, the supplier should be able to provide GMP certificates, CPP documentation, and a sample CoA.<\/li>\n<li><strong>Destination-market regulatory knowledge<\/strong>: A distributor familiar with the specific regulatory requirements of your destination market significantly reduces the risk of import delays.<\/li>\n<li><strong>Full chain traceability<\/strong>: The ability to trace a product from manufacturer to delivery point with documentation at every stage.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/lenus-healthcare.com\/en\/services\/pharmaceutical-wholesaler\/\">Lenus Health<\/a> works with qualified supply partners across Germany and the EU and provides complete documentation for every branded medicine shipment. Our team has direct experience with the regulatory requirements of Middle Eastern, Central Asian, and Latin American markets.<\/p>\n<blockquote><p><a href=\"https:\/\/lenus-healthcare.com\/en\/contact-us\/#form-contact\"><strong>For international supply and commercial inquiries regarding this product, please contact the Lenus Health sales team.<\/strong><\/a><\/p><\/blockquote>\n<p><strong id=\"Conclusion\">8. Conclusion<\/strong><\/p>\n<p>Branded medicines wholesale from Europe is a specialised field that requires regulatory knowledge, strong supply relationships, and the ability to manage complex documentation across multiple jurisdictions. Unlike generic pharmaceutical procurement, branded medicine sourcing involves distribution restrictions, destination-country registration requirements, and stock availability challenges.<\/p>\n<p>For patients in markets across the Middle East, Central Asia, and Latin America, many of these branded medicines are the only available treatment. Healthcare organisations and distributors serving these markets need a European supply partner who understands the regulatory environment, takes documentation seriously, and can be relied upon when supply conditions become difficult.<\/p>\n<p>If your organisation requires branded medicines sourced from Europe with full documentation and GDP-compliant logistics, we are happy to discuss your specific requirements.<\/p>\n<p><strong id=\"faq\">9. Frequently Asked Questions<\/strong><\/p>\n<ul>\n<li><strong>What is a branded medicine?<br \/>\n<\/strong>A branded medicine is a pharmaceutical product developed and marketed by the originating manufacturer under a proprietary trade name. These medicines are produced during the patent exclusivity period, during which no other manufacturer may legally produce the same compound. After patent expiry, other qualified manufacturers may produce bioequivalent generic versions.<\/li>\n<li><strong>Why are branded medicines from Europe more expensive than generics?<br \/>\n<\/strong>The higher price of branded medicines reflects the cost of research and development, clinical trials, regulatory approval, and patent lifecycle management. A new medicine typically requires ten to fifteen years and billions of dollars in investment before reaching the market.<\/li>\n<li><strong>Can branded European medicines be exported to any country?<br \/>\n<\/strong>Not necessarily. The exportability of a branded medicine depends on the regulatory requirements of both the origin country and the destination market. Some products carry distribution restrictions imposed by the manufacturer. Some destination markets require prior product registration before import is permitted.<\/li>\n<li><strong>What is the difference between a branded medicine and a biosimilar?<br \/>\n<\/strong>A biosimilar is a version of a biologic branded medicine developed by another manufacturer after the originator&#8217;s patent has expired. Unlike chemical generic medicines, which must demonstrate exact bioequivalence, biosimilars are highly similar but cannot be identical due to the complexity of biological manufacturing.<\/li>\n<li><strong>\u00a0What documentation is required to import branded medicines from Europe?<br \/>\n<\/strong>Standard documentation includes a CPP, a batch-specific CoA, a valid GMP certificate, Batch Release Records, and a Free Sale Certificate. Depending on the destination market, import permits, prior product registration, or additional regulatory certificates may also be required.<\/li>\n<li><strong>How long does it take to source branded medicines from a European wholesaler?<br \/>\n<\/strong>Products held in European distribution stock can typically ship within one to three weeks from purchase order confirmation. Products requiring direct sourcing from the manufacturer or subject to restricted distribution may require four to twelve weeks or longer.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p> EMA-Authorized Innovator Drug Supply and Distribution<\/p>\n","protected":false},"author":2,"featured_media":6839,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[120],"tags":[],"class_list":["post-6835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health<\/title>\n<meta name=\"description\" content=\"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health\" \/>\n<meta property=\"og:description\" content=\"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"Lenus Health\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-11T23:40:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"873\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"login-hashemzadeh-dash\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"login-hashemzadeh-dash\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/\"},\"author\":{\"name\":\"login-hashemzadeh-dash\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#\\\/schema\\\/person\\\/0abed38587372602833862aaf8e51e09\"},\"headline\":\"Branded Medicines Wholesale from Europe: What International Buyers Need to Know\",\"datePublished\":\"2026-07-11T23:40:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/\"},\"wordCount\":2154,\"publisher\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/branded-medicines-wholesale-europeTH.jpg\",\"articleSection\":[\"New medicines\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/\",\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/\",\"name\":\"Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/branded-medicines-wholesale-europeTH.jpg\",\"datePublished\":\"2026-07-11T23:40:02+00:00\",\"description\":\"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/branded-medicines-wholesale-europeTH.jpg\",\"contentUrl\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/branded-medicines-wholesale-europeTH.jpg\",\"width\":1600,\"height\":873,\"caption\":\"EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/branded-medicines-wholesale-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lenus-healthcare.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neue Medikamente\",\"item\":\"https:\\\/\\\/lenus-healthcare.com\\\/category\\\/neue-medikamente\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Branded Medicines Wholesale from Europe: What International Buyers Need to Know\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#website\",\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/\",\"name\":\"Lenus Health\",\"description\":\"Lenus Health Gmbh | Berlin\",\"publisher\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lenus-healthcare.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#organization\",\"name\":\"Lenus Health\",\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2017\\\/07\\\/Logo-pur.webp\",\"contentUrl\":\"https:\\\/\\\/lenus-healthcare.com\\\/wp-content\\\/uploads\\\/2017\\\/07\\\/Logo-pur.webp\",\"width\":1275,\"height\":298,\"caption\":\"Lenus Health\"},\"image\":{\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lenus-healthcare.com\\\/#\\\/schema\\\/person\\\/0abed38587372602833862aaf8e51e09\",\"name\":\"login-hashemzadeh-dash\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g\",\"caption\":\"login-hashemzadeh-dash\"},\"url\":\"https:\\\/\\\/lenus-healthcare.com\\\/en\\\/author\\\/login-hashemzadeh-dash\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health","description":"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/","og_locale":"en_US","og_type":"article","og_title":"Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health","og_description":"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.","og_url":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/","og_site_name":"Lenus Health","article_published_time":"2026-07-11T23:40:02+00:00","og_image":[{"width":1600,"height":873,"url":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg","type":"image\/jpeg"}],"author":"login-hashemzadeh-dash","twitter_card":"summary_large_image","twitter_misc":{"Written by":"login-hashemzadeh-dash","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#article","isPartOf":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/"},"author":{"name":"login-hashemzadeh-dash","@id":"https:\/\/lenus-healthcare.com\/#\/schema\/person\/0abed38587372602833862aaf8e51e09"},"headline":"Branded Medicines Wholesale from Europe: What International Buyers Need to Know","datePublished":"2026-07-11T23:40:02+00:00","mainEntityOfPage":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/"},"wordCount":2154,"publisher":{"@id":"https:\/\/lenus-healthcare.com\/#organization"},"image":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg","articleSection":["New medicines"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/","url":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/","name":"Branded Medicines Wholesale Europe | EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health","isPartOf":{"@id":"https:\/\/lenus-healthcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#primaryimage"},"image":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg","datePublished":"2026-07-11T23:40:02+00:00","description":"Lenus Health is a GDP-certified pharmaceutical wholesaler in Germany specializing in branded medicines wholesale for international markets. Full EMA documentation, WDL authorization, and cold chain logistics.","breadcrumb":{"@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#primaryimage","url":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg","contentUrl":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2026\/06\/branded-medicines-wholesale-europeTH.jpg","width":1600,"height":873,"caption":"EMA-Authorized Innovator Drug Supply and Distribution-Lenus Health"},{"@type":"BreadcrumbList","@id":"https:\/\/lenus-healthcare.com\/branded-medicines-wholesale-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lenus-healthcare.com\/en\/"},{"@type":"ListItem","position":2,"name":"Neue Medikamente","item":"https:\/\/lenus-healthcare.com\/category\/neue-medikamente\/"},{"@type":"ListItem","position":3,"name":"Branded Medicines Wholesale from Europe: What International Buyers Need to Know"}]},{"@type":"WebSite","@id":"https:\/\/lenus-healthcare.com\/#website","url":"https:\/\/lenus-healthcare.com\/","name":"Lenus Health","description":"Lenus Health Gmbh | Berlin","publisher":{"@id":"https:\/\/lenus-healthcare.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lenus-healthcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lenus-healthcare.com\/#organization","name":"Lenus Health","url":"https:\/\/lenus-healthcare.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lenus-healthcare.com\/#\/schema\/logo\/image\/","url":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2017\/07\/Logo-pur.webp","contentUrl":"https:\/\/lenus-healthcare.com\/wp-content\/uploads\/2017\/07\/Logo-pur.webp","width":1275,"height":298,"caption":"Lenus Health"},"image":{"@id":"https:\/\/lenus-healthcare.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lenus-healthcare.com\/#\/schema\/person\/0abed38587372602833862aaf8e51e09","name":"login-hashemzadeh-dash","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b58400e93864034c4119dff6d018160c0ebf646c52f088b18a3bde50dc9174f6?s=96&d=mm&r=g","caption":"login-hashemzadeh-dash"},"url":"https:\/\/lenus-healthcare.com\/en\/author\/login-hashemzadeh-dash\/"}]}},"_links":{"self":[{"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/posts\/6835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/comments?post=6835"}],"version-history":[{"count":7,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/posts\/6835\/revisions"}],"predecessor-version":[{"id":6851,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/posts\/6835\/revisions\/6851"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/media\/6839"}],"wp:attachment":[{"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/media?parent=6835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/categories?post=6835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lenus-healthcare.com\/en\/wp-json\/wp\/v2\/tags?post=6835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}